Transmedics Group Inc share price logo

Transmedics Group Inc Share Price

NASDAQ: TMDX

Mid Cap

$130.92

-3.85

(-2.86%)

Live

as on

Transmedics Group Inc Stock Performance

as on March 11, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $129.37
    $135.12
    downward going graph

    1.18%

    Downside

    3.21%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $62.23
    $156.00
    downward going graph

    52.47%

    Downside

    19.16%

    Upside

    downward going graph

Transmedics Group Inc share price movements today

Previous Close
$134.77
Open
$133.32
Volume
581.1K
Day's Low - High
$129.37 - $135.12
52 Week Low - High
$62.23 - $156.00

Transmedics Group Inc Historical Returns

1 Month Return
-3.25 %
3 Month Return
+ 2.71 %
1 Year Return
+ 104.1 %
3 Year Return
+ 88.44 %
5 Year Return
+ 301.34 %

Transmedics Group Inc Stock Fundamentals & Key Indicators

Check Transmedics Group Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.4B

EPS (TTM)

2.4986

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

11.88%

PE Ratio (TTM)

26.61

Industry PE ratio

7.871681415929204

PEG Ratio

0

EBITDA

134.5M

Revenue (TTM)

605.5M

Profit Margin

31.43%

Return On Equity TTM

54.24%

Transmedics Group Inc Stock Valuation

Track how Transmedics Group Inc P/E has moved over time to understand its valuation trends.

Transmedics Group Inc in the last 5 years

  • Overview

  • Trends

Lowest (-134.30x)

June 30, 2023

Industry (7.87x)

March 10, 2026

Today (26.61x)

March 10, 2026

Highest (163.92x)

September 30, 2024

LowHigh

Today’s Price to Earnings Ratio: 26.61x

Transmedics Group Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Transmedics Group Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$4.4B301.34%26.6131.43%
BUY$105.9B82.77%36.7814.44%
BUY$139.5B52.42%43.512.92%
BUY$116.7B-23.02%25.3913.00%
BUY$190.4B-2.79%29.3714.72%

Stock Returns calculator for Transmedics Group Inc Stock including INR - Dollar returns

The Transmedics Group Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Transmedics Group Inc investment value today

Current value as on today

₹2,03,466

Returns

₹1,03,466

(+103.47%)

Returns from Transmedics Group Inc Stock

₹98,274 (+98.27%)

Dollar Returns*

₹5,192 (+5.19%)

Analyst Recommendation on Transmedics Group Inc Stock

Based on 13 analysts

BUY

84.62%

Buy

15.38%

Hold

0.00%

Sell

Based on 13 analysts, 84.62% of analysts recommend a 'BUY' rating for Transmedics Group Inc. Average target price of $157.55

Transmedics Group Inc Share Price Target

Get share price movements and forecasts by analysts on Transmedics Group Inc.

What analysts predicted

16.9%UPSIDE

Target Price

$157.55

Current Price

$130.92

Analyzed by

13 Analysts

Target

$157.55

Transmedics Group Inc target price $157.55, a slight upside of 16.9% compared to current price of $130.92. According to 13 analysts rating.

Transmedics Group Inc Stock’s Investor Sentiment and Interest

Investment in Transmedics Group Inc Shares on INDmoney has dropped by -71.07% over the past 30 days, indicating reduced transactional activity.

Time period: to

Change:-71.07% versus previous 30 day period

Search interest for Transmedics Group Inc Stock has decreased by -61% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-61% versus previous 30 day period

Transmedics Group Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
66
81
96
114
108
121
143
157
143
160
Gross Profit
40
47
59
69
60
72
88
96
84
93
Operating Income
-28
2
12
12
3
8
27
36
23
21
EBITDA
-21
11
20
20
13
16
36
46
33
32
Interest Expense
3
3
3
3
3
3
3
3
3
3
Depreciation
1
3
4
4
5
5
6
6
6
7
Income Before Tax
-26
3
12
12
4
6
26
36
23
21
Income Tax Expense
-1
0
0
0
0
0
0
1
-1
-83
Net Income
-25
4
12
12
4
6
25
34
24
105
Net Profit Margin
-38.27%
4.97%
12.59%
10.67%
3.88%
5.64%
17.89%
22.18%
16.91%
65.55%

Transmedics Group Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
6
7
13
23
25
30
93
241
441
605
Gross Profit
0
2
5
13
16
21
65
154
262
362
Operating Income
-22
-20
-20
-29
-26
-39
-31
-28
37
108
EBITDA
-22
-19
-20
-27
-23
-38
-28
-7
69
148
Interest Expense
0
1
2
4
3
3
3
10
14
13
Depreciation
-
0
0
1
1
1
3
5
19
27
Income Before Tax
-24
-20
-23
-33
-28
-44
-36
-26
35
107
Income Tax Expense
0
0
0
0
0
0
0
-1
0
-82
Net Income
-24
-20
-23
-33
-28
-44
-36
-25
35
190
Net Profit Margin
-387.58%
-270.96%
-182.50%
-142.12%
-112.13%
-146.11%
-38.77%
-10.36%
8.03%
31.43%

Transmedics Group Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
4
12
12
4
6
25
34
24
105
Operating Cash Flow
8
-3
25
6
19
-2
91
69
34
Investing Cash Flow
-41
-44
-23
-47
-13
-27
-9
-7
-15
Financing Cash Flow
0
3
10
7
1
3
7
3
3
Change in Cash
-32
-44
12
-32
6
-26
90
65
22

Transmedics Group Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-20
-23
-33
-28
-44
-36
-25
35
190
Operating Cash Flow
-23
-25
-32
-30
-28
-45
-13
48
192
Investing Cash Flow
24
12
-60
-41
29
54
-193
-129
-59
Financing Cash Flow
0
22
92
75
1
167
400
22
16
Change in Cash
2
8
0
4
0
175
193
-58
151

Global Institutional Holdings in Transmedics Group Inc

Funds
Holdings
Hood River Capital Management LLC
2.01%
Morgan Stanley - Brokerage Accounts
1.6%
T. Rowe Price Associates, Inc.
1.16%
UBS Asset Mgmt Americas Inc
3.12%
Geode Capital Management, LLC
2.37%

Transmedics Group Inc News & Key Events

  • img

    Today's Timeline - 08 March

    Sun, 01:45 PM

    -

    TransMedics reports 2025 revenue of $605.5 million, a 37% increase, with OCS Liver accounting for 36% of U.S. transplants.

    Mon, 03:40 AM

    -

    TransMedics Group faces short-term share price decline despite strong long-term performance and fundamentals.

Insights on Transmedics Group Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, TMDX has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 24.31M → 105.38M (in $), with an average increase of 76.9% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 143.82M → 160.76M (in $), with an average increase of 10.5% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, TMDX has outperformed top 5 stocks with highest market-cap in its industry

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, TMDX stock has moved down by -8.9%

About Transmedics Group Inc

transmedics inc. is the world’s leader in portable ex-vivo perfusion and assessment of donor organs for transplantation. the company was founded to address the need for more and better organs for transplantation, and is focused on transforming the standard of care – increasing organ utilization, improving patient outcomes, and reducing transplant costs throughout the heath care system. the ocs™ lung and ocs™ heart systems are ce-marked and in commercial use outside the us, and are currently being reviewed by the fda for u.s. market access. the ocs™ liver is in an fda pivotal trial (the ocs™ liver protect trial) in the united states and a ce-mark trial in (the revive trial) in europe.
OrganisationTransmedics Group Inc
Headquarters200 Minuteman Road, Andover, MA, United States, 01810
IndustryMedical Specialties
CEODr. Waleed H. Hassanein M.D.
E-voting on sharesClick here to vote

Key Management of Transmedics Group Inc

Name

Title

Dr. Waleed H. Hassanein M.D.

Founder, President, CEO & Director

Mr. Gerardo Hernandez

CFO & Treasurer

Mr. Nicholas Corcoran

Senior Vice President of Supply Chain & Operations

Mr. Anil Ranganath

Senior VP, General Counsel & Corporate Secretary

Dr. Tamer I. Khayal M.D.

Chief Commercial Officer

Ms. Miriam C. Provost Ph.D.

Vice President of Global Regulatory Affairs

FAQs

What is Transmedics Group Inc share price today?

Transmedics Group Inc share price today is $130.92 as on . Transmedics Group Inc share today touched a day high of $135.12 and a low of $129.37.

What is the 52 week high and 52 week low for Transmedics Group Inc share?

Transmedics Group Inc share touched a 52 week high of $156 on and a 52 week low of $62.23 on . Transmedics Group Inc stock price today i.e. is trending at $130.92,which is 16.08% down from its 52 week high and 110.38% up from its 52 week low.

What is Transmedics Group Inc's market capitalisation today?

Transmedics Group Inc market capitalisation is $0.00T as on .

How to invest in Transmedics Group Inc Stock (TMDX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Transmedics Group Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Transmedics Group Inc Shares that will get you 0.0115 shares as per Transmedics Group Inc share price of $130.92 per share as on March 11, 2026 at 1:29 am IST.

What is the minimum amount required to buy Transmedics Group Inc Stock (TMDX) from India?

Indian investors can start investing in Transmedics Group Inc (TMDX) shares with as little as ₹91.833 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹918.33 in Transmedics Group Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Transmedics Group Inc share’s latest price of $130.92 as on March 11, 2026 at 1:29 am IST, you will get 0.0764 shares of Transmedics Group Inc. Learn more about fractional shares .

What are the returns that Transmedics Group Inc has given to Indian investors in the last 5 years?

Transmedics Group Inc stock has given 301.34% share price returns and 26.32% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?